California's Multibillion-Dollar Stem Cell and Gene Therapy Agency Headed Towards New Directions
New priorities are "more crucial than ever," losers and winners expected to emerge, plus CIRM's financial fate
California’s stem cell and gene therapy program is down to its last $3.5 billion and is setting the stage for fresh projects that it believes would be the most likely to shape the future and have a major, long-term impact.
Just exactly what those projects may be is unclear. Nonetheless, new priorities are “more crucial than ever,” the agency…
Keep reading with a 7-day free trial
Subscribe to The California Stem Cell Report to keep reading this post and get 7 days of free access to the full post archives.